免疫抑制剂在肾脏病中的应用学习资料.pptVIP

Baseline FK506 CTX P Number 39 34 Age 47.2±11.9 48.6±11.6 0.05 Gender (M/F) 23/16 18/16 0.05 Histology (I/II/III) 16/21/2 16/17/1 0.05 Urine protein（g/24h） 7.71 ± 3.93 7.28 ±3.91 0.05 SAlb（g/L） 23.1 ±4.25 23.1±4.81 0.05 Scr（umol/L） 85.3 ± 38.1 76.1 ±22.6 0.05 * 6个月的疗效 Tacrolimus CTX Total Complete remission 10 8 18 Partial remission 21 11 32 Treatment Failure 2 8 10 Total 33 27 60 The remission rate (CR+PR) was significantly higher in Tacrolimus group than that in CTX group at half year (93.9% vs. 70.4%，P0.05) * 1年时的疗效 FK506 CTX Total Complete remission 6 5 11 Partial remission 13 4